meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Alzheimer's disease (AD)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Alzheimer's disease often begins due to certain gene mutations, ongoing inflammation, and prolonged unhealthy lifestyle choices, including lack of physical activity and a diet high in sugar.
Alzheimer's Disease (AD) is the most common neurodegenerative disorder, characterized by the extracellular deposition of amyloid-beta (Aβ) and intracellular accumulation of hyperphosphorylated aggregated tau. It is a chronic, age-related progressive neurological disorder accounting for approximately 80% of dementia cases…
References (Sources)
- 2021 Alzheimer's disease facts and figures
- Alzheimer's disease research: the future of BACE inhibitors
- AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation
- Gut Microbiota and Dysbiosis in Alzheimer’s Disease: Implications for Pathogenesis and TreatmentReview
- The Endocannabinoid System: A Bridge between Alzheimer’s Disease and Gut Microbiota
- Twenty years of the Alzheimer’s disease amyloid hypothesis: A genetic perspective
- Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration